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Abstract
Neuronal communication is tightly regulated in time and space. Following neuronal activation, an
electrical signal triggers neurotransmitter (NT) release at the active zone. The process starts by
the signal reaching the synapse followed by a fusion of the synaptic vesicle (SV) and diffusion of the
released NT in the synaptic cleft. The NT then binds to the appropriate receptor and induces a
membrane potential change at the target cell membrane. The entire process is controlled by a fairly
small set of synaptic proteins, collectively called SYCONs. The biochemical features of SYCONs
underlie the properties of NT release.
SYCONs are characterized by their ability to detect and respond to changes in environmental
signals. For example, consider synaptotagmin I (Syt1), a prototype of a protein family with over 20
gene and variants in mammals. Syt1 is a specific example of a multi-sensor device with a large
repertoire of discrete states. Several of these states are stimulated by a local concentration of
signaling molecules such as Ca2+. The ability of this protein to sense signaling molecules and to
adopt multiple biochemical states is shared by other SYCONs such as the synapsins (Syns). Specific
biochemical states of Syns determine the accessibility of SV for NT release. Each of these states is
defined by a specific alternative spliced variant with a unique profile of phosphorylation modified
sites.
The plasticity of the synapse is a direct reflection of SYCON's multiple biochemical states. State
transitions occurs in a wide range of time scales, and therefore these molecules need to cope with
events that last milliseconds (i.e., exocytosis in fast responding synapses) and with events that can
carry on for many minutes (i.e., organization of SV pools). We suggest that SYCONs are optimized
throughout evolution as multi-sensor devices. A full repertoire of the switches leading to
alternation of protein states and a detailed characterization of protein-protein network within the
synapse is critical for the development of a dynamic model of synaptic transmission.
Background
The structure and function of the nerve terminal has been
a topic of extensive research for many years [1,2]. It is only
in recent years, however, that the molecular complexity of
this structure has been fully appreciated. The availability
of complete genomes for different organisms and the
development of single molecule detection techniques
provided new clues relating to the links between the mol-
ecules involved in the structural organization of the syn-
apse and its function [3,4].
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From neuronal properties to molecular properties
Most research in computational neuroscience is con-
ducted from a 'systems biology' perspective. In this
approach, each single neuron is considered as an integra-
tor device, joined to a neuronal network [5,6]. A desirable
goal is to develop a simulator that will accurately predict
the behavior of the neuronal network, and its properties
(i.e., synchronization, rhythm, robustness). To accom-
plish such an ambitious task, it is crucial to incorporate
the most accurate biochemical and biophysical properties
of all components. There is no single component respon-
sible for the overall neuronal properties. On the contrary,
the function of the neuron is a reflection of time and space
related events that are sensitive to ion compositions,
metabolites and their fluxes, energy supply, second mes-
senger levels, cell anatomy, lipid composition, degree of
network connectivity and more. Fortunately, accurate
techniques have been developed over the years for direct
measurements of neurons in-vivo and in-vitro with high
spatial and temporal resolution [7]. Furthermore, as a
result of the sequencing of the human genomes and of
hundreds of additional genomes, many genomic data-
bases have become available [8,9]. Hence, there is now an
almost complete list of genes and proteins that compose
the synapse.
We refer to the synapse as the structure of the nerve termi-
nal that is composed of the presynaptic site, the synaptic
cleft and the postsynaptic site. Each synapse may have a
somewhat specialized composition of proteins and
unique architectural properties. Still, it is safe to assume
that a generic mammalian synapse will have a set of over
100 different proteins that are distributed between the
pre- and postsynaptic sites [10-12]. We limit our discus-
sion to a generic presynaptic site of the mammalian CNS
nerve terminal. We will consider a minimal set of ~50 pro-
teins that is directly involved in the maintenance of the
presynaptic site and in the exocytosis and endocytosis of
SVs [13].
The "Part List" of pre-synaptic proteins
The components of mammalian presynaptic sites were
identified through the use of a combination of genetic
and biochemical methods. Most of these proteins belong
to gene families and are often also expressed as alternative
spliced variants. These proteins are listed in Table
1[11,14].
A static table is unable to capture the dynamic nature of
the synapse. Manipulating selected gene products and
measuring the biochemical and physiological outcome
provided the essential information for reconstructing a
dynamic model of the synapse. Such studies lead to a
wider view of synaptic proteins. Specifically, replacing the
notion of a protein as a single entity with a more elaborate
description where each protein sequence is a collection of
identified biochemical states. A biochemical state is a
static description of a protein beyond its amino acid
sequence. This includes a detailed description on all
amino acids that are modified and the nature of the mod-
ification, the cellular location, the position of small ions
and molecules that are bound to the protein, the interac-
tion with other proteins/lipids etc.
What are the 'molecular knobs' that dictate the transition
from one biochemical state of a protein to another? How
many biochemical defined states are valid in vivo? Are all
possible states compatible or alternatively, which ones are
mutually exclusive? Can we incorporate the formulation
of biochemical protein states for a better understanding of
neurological and mental diseases? In this survey, we will
illustrate the concept of sequential molecular states in
synaptic proteins by exemplifying it for a few key proteins
that were postulated in the control of neurotransmitter
(NT) release in the synapse.
The effect of switching a protein from one biochemical
state to another is a basic tenet of most signal transduction
cascades. A switch between alternative states often leads to
(i) a change in the protein sub-cellular localization or (ii)
a change in affinity towards potential partners, resulting
in an alternative protein-protein network. We will not dis-
cuss long-term effect in neuronal activity that is often
associated with induction of gene expression and with
subsequent morphological changes.
Synaptic vesicle proteins
Many parallel processes take place in the presynaptic site
[15]. For example, the organization of the sub-membrane
cytomatrix, sorting and trafficking [16], maintenance of
membrane potential, establishment of feedback loops for
controlling the level of secretion [17] and the partition of
SVs into functionally diverse pools [18]. Still, the function
of the synapse is by large the regulation of the SV exo- and
endocytosis cycle.
Most components that participate in the SV life cycle had
been identified a decade ago [19]. However, genetic
manipulation of synaptic proteins in model organisms
has shed light on their function in the SV life cycle [20].
Probes designed specifically to detect transient protein
interacting states were introduced. Among these probes
are bacterial neurotoxins [21], fluorescence in vivo dyes
that capture a single SV fusion event [22] and antibodies
that specifically detect a transient step in the life cycle of
SV. Using such probes, the dynamic protein-protein inter-
action network in the synapse has been characterized
[19,23]. It was concluded that only a few tens of proteins
participate in the exocytosis and endocytosis cycle in
mammalian CNS synapse. We assigned each protein toBMC Neuroscience 2006, 7(Suppl 1):S4
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Table 1: A list of major pre-synaptic proteins in the mammalian synapse.
Protein ID UniProt Symbol HUGOa Localization TMD Commentb
1. Amisyn Q8NFX7 STXBP6 Cyt No Exo
2. Amphyphysin P49418 AMPH SV, PM No Endo
3. Basoon Q9UPA5 BSN Cyt No M
4. Bridging integrator O00499 BIN1 Cyt, SV No M*
5. CAPS Q9ULU8 CADPS Cyt, SV No Exo
6. CASK O14936 CASK Cyt No M. Exo
7. CASKIN Q8WXD9 CASKIN1 Cyt, PM No M. Exo
8. CAST O15083 CAST1 Cyt, PM No M
9. Complexin Q6PUV4 CPLX2 PM No Exo
10. CSP Q9H3Z4 DNAJC5 Cyt, SV No M, Exo
11. Doc2 DOC2A Q14183 SV No Exo
12. Dynamin P50570 DNM2 Cyt, SV No M, Endo
13. Epsin Q9Y6I3 EPN1 Cyt No M, Endo
14. Hrs-2 O14964 HGS Cyt, SV No M
15. Intersectin Q15811 ITSN1 CytSV NoNo Endo, M
16. Latrophilin O94910 LPHN1 PM Yes Exo
17. Liprin-α Q13136 PPFIA1 Cyt No M*
18. Mint/X -11 Q02410 APBA1 Cyt No M, Exo
19. Munc-13 Q9UPW8 UNC13A Cyt, PM No M, Exo -Endo
20. Munc-18 O00186 STXBP3 Cyt, PM No Exo
21. Neurexin P58400 NRX1 PM Yes M, Exo
22. NSF NSF P46459 SV, Cyt No M*
23. NT transporter P23975 SLC6A2 SVPM Yes M
24. NTvesicle 
transporter
Q16572 SLC18A3 PMSV Yes M
25. P/Q Ca2+ channel O00555 CACNA1A PM Yes Exo
26. Pallklin Q9UL45 PLDN Cyt, SV No M
27. Piccolo Q9Y6VO PCLO Cyt No M
28. Rab3 P20336 RAB3A Cyt, SV No M, Exo *
29. Rabconnectin-3 Q8WTV7 DMXL2 Cyt No M, Exo
30. Rabphilin Q9Y2JO RPH3A SV No M, Exo
31. RIM Q86UR5 RIMS1 PM No M, Exo
32. RIMS binding 
protein
O15034 RIMBP2 SV Yes Exo, M *
33. SCAMP O15126 SCAMP1 SV Yes M
34. SNAP-25 P60880 SNAP25 PM No Exo
35. Snapin O95295 SNAPAP PM, Cyt No Exo, Endo
36. Stonin-2 Q8WXE9 STN2 Cyt No Endo
37. SV2 Q7L0J3 SV2A SV Yes Exo, M
38. Synapsin P17600 SYN1 SV No M
39. synaptogyrin O43759 SYNGR1 SV Yes Exo
40. Synaptojanin O43426 SYNJ1 Cyt PM No Endo*
41. Synaptophysin P08247 SYP SV Yes M, Exo
42. Synaptotagmin P21579 SYT1 SV Yes Exo, Endo
43. Syntaphilin O15079 SNPH PM Yes Exo
44. Syntaptoporin Q8TBG9 SYNPR PM Yes Exo
45. Syntaxin Q16623 STX1A PM Yes Exo
46. Tomosyn Q5T5C0 STXBP5 PM Yes Exo
47. VAMP P63027 VAMP1 SV Yes Exo
48. VAT-1 Q99536 VAT1 SV No M
49. Vo P27449 ATP6V0C PM Yes Exo, Endo
50. α-SNAP P54920 NAPA SV No M, Exo
Most proteins that function in the mammalian SV life cycle are listed. aProtein symbols are provided by HUGO, the Human Genome Organization 
Gene nomenclature committee http://www.gene.ucl.ac.uk/nomenclature/. IDs are according to UniProt database http://www.expasy.uniprot.org. 
bProteins listed are from Human are marked according to their main function in exocytosis (Exo), endocytosis (Endo) and synapse maintenance (M). 
The proteins with intrinsic enzymatic activity are marked by an asterisk (*). Proteins whose function is in building, shaping and maintenance of the 
pre-and postsynaptic structures are not included. For simplicity only one representative of a gene family is listed. PM, plasma membrane; Cyt, 
cytosol; TMD, transmembrane domain.BMC Neuroscience 2006, 7(Suppl 1):S4
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one of the following functions (i) structure and organisa-
tion of the synapse (ii) exocytosis and (iii) endocytosis
(Table 1). The actual complexity is much higher as many
of the listed proteins belong to relatively large gene fami-
lies. An extreme example is the Rab family with ~60 genes
and multiple variants in mammals [24]. While the list of
proteins in the presynaptic site is fairly large, only a few
dictate the characteristics of NT release.
Once we focus on proteins directly involved in the SV
fusion event, we are left with few proteins of the exocy-
totic core (yet each may belong to a family of closely
related proteins): the SNAREs (VAMP, syntaxin and
SNAP-25), their immediate associated protein synapto-
tagmin (Syt) and the voltage dependent Ca2+ channel
(VDCC) [11].
Results from an in vitro reconstitution assay for vesicle
fusion showed that the SNAREs in isolation fail to mimic
the temporal and spatial characteristics of SV release [25].
However, proteins of the minimal exocytotic core are
beautifully designed for the sequence of events leading to
SV fusion.
Proteins as multi-sensor proteins of NT release
The notion that proteins in the synapse act as multi-sensor
devices is very attractive as it provides a mechanistic
model that relies on the proteins themselves being inte-
grating devices. The requirement for the synapse to release
its NT in a fully controllable manner depends on: (i) an
efficient coupling between the stimulating signals and the
SV life cycle, (ii) an inherent mechanism for sensing the
exact physiological state of the synapse, and (iii) a direc-
tionality in the molecular intermediates that leads to
cycling of exo- and endocytosis. We will elaborate only on
the latter aspect.
Directionality in an enzymatic reaction is achieved by a
coordinated reduction in the substrates associated with an
increase in the reaction products. The mechanism that
ensures directionality in cellular processes is often
dependent on a sequence of conformational changes in
some key proteins. A 'textbook' example is the cycle of G-
protein activation, one of the best studied switches in sig-
nal transduction pathways. G-protein carries an intrinsic
GTPase activity that results in a conformational change in
the protein, thus switching it from an active to an inactive
state (Fig. 1A). The energy cost, in the form of GTP, is asso-
ciated with each cycle, thus the extent of the reaction
reflects the physiological state of the cell. Furthermore, a
set of proteins can detect the G-protein in only one out of
several alternative conformations which leads to the cyclic
operation of the G-protein. The balance among all regula-
tors of G-proteins defines the speed, direction and extent
of the signal mediated by the G-proteins.
The G-protein is an example for a protein that is a focal
point for regulatory proteins replenishing the cycle. This
example is valid also to proteins that control the endo-
and exocytosis in nerve terminals (Fig. 1B). A small set of
proteins from the presynaptic site, collectively referred to
as SYNCONs (Synaptic Control of Neurotransmitter
release proteins) are characterized by the following fea-
tures:
• Binding directly to the exocytotic core
￿ Having modular structural and functional domain
architectures
￿ Having measurable distinct biochemical states that are
dependent on signaling molecules
￿ The biochemical states are temporary and reversible
￿ Participating in a transient protein interaction network
￿ Belonging to protein families that are conserved
throughout evolution.
The family of synaptotagmins and specifically synaptotag-
min I (Syt1) fully fulfill the features of SYNCONs, thus
functioning as multi-sensor devices that dictate the prop-
erties of the NT release in most synapses.
(i) A genuine protein of the exocytotic core
Synaptotagmin 1 (Syt1) was initially identified as a pro-
tein interacting directly with syntaxin [26]. It was identi-
fied again in the search for proteins that interact with the
α-latrotoxin, the black widow spider neurotoxin that
causes a collapse of the control of NT release [27]. Further-
more, Syt1 was independently identified as a partner of
the VDCC that is activated in response to action potential
in fast synapses [14]. Through this interaction with the
VDCC [28] a modulation and competition between Syt1
and the plasma membrane SNAREs (syntaxin and SNAP-
25) is confirmed [29]. Thus, Syt1 is a direct modulator of
the core proteins of the exocytotic machinery. An addi-
tional role of Syt1 in the endocytotic phase of the SV cycle
was also confirmed through its direct interaction to AP2
and other components of the endocytotic apparatus
(Table 1). Taken together, Syt1 is clearly a genuine part of
the core of proteins that control NT release and SV fusion
[30].
(ii) Modularity in domain architecture
Syt1 is composed of the following modular units: a short
N-terminal luminal sequence, a single transmembrane
(TMD) domain, a linker sequence and two C2 domains
(the C2A and C2B domains). The protein is localized to
the membrane of the SV with the C2 domains facing theBMC Neuroscience 2006, 7(Suppl 1):S4
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cytoplasm (Fig. 2) [31,32]. This basic modular structure is
maintained throughout evolution and is identical to that
found in fly, worm, frog, snail, squid and more [33]. Syt1
is composed of few autonomous domains (i.e. C2A, C2B,
luminal domain, TMD). Such design allows each domain
to act almost independently in sensing different aspects of
cell physiology. Such modularity is the basis for the prop-
erties of Syt1 as a multi-sensor. Interestingly, several Syt-
like proteins expressed in the brain that lack TMD were
identified. The role of these molecules as competitors for
Syt1 is currently being tested (Linial, unpublished).
(iii) Dynamic sensor for small signaling molecules
The C2A domain of Syt1 may bind three Ca2+ ions and
the C2B domain two Ca2+ ions [33,34]. This biochemical
observation is supported by structural studies, as well as
by direct mutagenesis of key residues that coordinate the
Ca2+ ions [31]. The intrinsic Ca2+ affinity of the C2
domains is very low but following binding to the nega-
tively charged phospholipid membranes, the affinity
increases by ~1000 fold to reach a micromolar range. The
binding of Ca2+ to C2 domains induces a change in the
molecule that can be now viewed as a new (biochemical)
state. A link between the number of bound ions in Syt1
and the capacity of the protein to act as a sensor for exo-
cytosis was shown [35]. Considering all possible combi-
nation of Ca2+ occupancy one can theoretically list 12
'states' for Syt1 with the simplified assumption that only
the number of Ca2+ ions and not their exact position is
relevant. This number can reach 32 individual states once
the actual position of each of the Ca2+ ions is considered.
Illustration of the rich repertoire of potential biochemical
states in view of Ca2+ occupancy is shown in Fig. 3.
Syt1 is capable of binding and integrating information for
additional signaling molecules such as the inositol tetrak-
isphosphate (IP4) and other inositol polyphosphates (IP5
and IP6). These molecules bind to the basic amino acid
stretch within the C2B domain (Fig. 2). The affinity of
Syt1 to Ca2+ is modulated according to the binding of
inositol polyphosphate moieties [30], the by-products of
extensive stimulation of the nerve terminals. The concen-
tration of free Ca2+ and IP4 in the synapse defines a fairly
complex binding competition curve for Syt1. In view of
Syt1, the number of biochemical defined states becomes
enormous. Syt1 states that are defined by Ca2+ and IP4
reflect the status of the synapse for a time scale that is in
the millisecond and tens of milliseconds range, respec-
tively.
(iv) Protein-protein interaction network
The signaling molecules that bind to Syt1 are a direct
reflection of the level of activity of that synapse. How is
the molecule able to transmit and convey this informa-
tion to the exocytosis machinery and in particular to the
fusion pore? The SNARE proteins can be viewed as the
minimal set of proteins necessary to facilitate the creation
of the fusion pore. Studies that addressed the importance
of Syt1 were performed in-vitro in a minimal fusion set-
ting or in a physiologically impaired setting [36]. The ves-
The cycle of activation and inactivation of proteins that drive a cellular process (A) the associated regulators of heterotrimeric  G-proteins (B) the cycle of synaptotagmin (Syt) according to interaction with signaling molecules, phospholipids (PL), additional  SYNCONs and its self oligomerization (Self). Figure 1
The cycle of activation and inactivation of proteins that drive a cellular process (A) the associated regulators of heterotrimeric 
G-proteins (B) the cycle of synaptotagmin (Syt) according to interaction with signalling molecules, phospholipids (PL), addi-
tional SYNCONs and its self oligomerization (Self). For details see text.BMC Neuroscience 2006, 7(Suppl 1):S4
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icle fusion in such artificial systems takes minutes rather
than milliseconds. In the absence of Syt1, the SNAREs lack
the 'stimulus-response' coupling expected from the exocy-
totic event in a functional synapse. The affinity of Syt1 to
the exocytotic machinery is Ca2+ and IP4 dependent. This
is in addition to the intrinsic capacity Syt1 exhibits in iso-
lation for binding these signaling molecules (Fig. 2).
Binding Syt1 to SNARE complexes has two components,
Ca2+ dependent and independent. Syt1 can bind to the
preassembled SNARE complex in the absence of Ca2+,
but as Ca2+ flows in, it switches to the phospholipid
membrane and inserts some of the hydrophobic residues
into the lipid layer (Fig 1B). The assumption is that bind-
ing of C2 domains to the phospholipids accelerates the
assembly of the SNARE dependent fusion pore. An addi-
tional facet of the Syt1 biochemical 'multi state' model is
the ability of the molecule to oligomerize (Fig. 1B). Syt1
can form homodimers and even higher orders of multim-
ers via its own TMD or directly via the C2B domain. But,
only the C2B dependent oligomerization is Ca2+-depend-
ent. A short conserved region of polybasic residues (Fig 2,
KK) in the C2B domain was shown to be critical for the
Ca2+-dependent NT release and also for the binding to
syntaxin-SNAP25 pair. This pair is a prerequisite for the
assembly of the SNARE complex. Considering this, Syt1
may be essential to coordinate the fine apposition of the
vesicle, relative to the Ca2+ channel at the initiation of the
fusion pore [37]. In the event that IP4 binds to these poly-
basic residues, it inhibits SNARE interaction competitively
[33]. While we have focused on the delicate balance of
Syt1-SNAREs interaction in binding of the signaling mol-
ecule, other synaptic molecules (i.e. AP2 endocytotic
adaptor, Neurexin, SV2, the Ca2+ channels, Fig. 2) are typ-
ically sensitive to the Syt1 biochemical status as well.
(v) Reversibility of biochemical states
Most of the discussion above relies on in-vitro binding
experiments. However, post-translational modification
A schematic view of synaptotagmin1 (Syt1). Figure 2
A schematic view of synaptotagmin1 (Syt1).  Each functional domain is differently colored. Small molecules that interact 
with Syt1 (blue letters) and the post translational modifications (black letters) are listed. Proteins of the exocytotic apparatus 
and their unique combinations are marked in gray. Additional proteins that were shown to interact with Syt1 are shown in red. 
C2C is the linker sequence between the two C2 domains. Modification sites for N- and O-glycosylations are marked as N- and 
O-, respectively. TMD, transmembrane domain; KK, a stretch of basic residues that defines the binding site for inositol 
polyphosphates [30].BMC Neuroscience 2006, 7(Suppl 1):S4
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(PTM) of Syt1 provides more information on 'stimulus
response' coupling. There are three sites of phosphoryla-
tion (for different kinases) [38], two sites of glycosylation
at the N' luminal terminal and sites for lipid modification
in the vicinity of the TMD. All these modifications were
confirmed in vivo and in vitro (Fig. 2). More significantly,
the phosphorylation state of the molecule defines the
degree of interaction with syntaxin-SNAP25 pair, and
therefore may rebalance the chain of reaction leading to
Ca2+ dependent SV fusion. These PTMs increase enor-
mously the number of biochemical states of Syt1. These
states may drive (or inhibit) the interaction with addi-
tional large number of partner proteins. The activity of dif-
ferent kinases and phosphatases in the synapse is often
associated with the level of plasticity, learning and mem-
ory [39]. It is thus tempting to postulate that SYNCONs
are the first to respond to these modifying enzymes.
(vi) Protein family – evolutionary perspective
Syts in human belong to a gene family composed of about
17 genes and several related Syt-like proteins [40]. Some
of the genes also seem to be expressed as different spliced
variants [41]. A distinction in biochemical properties for
the different members of the Syt family was drawn in view
of (i) their affinity for divalent ions such as Ca2+ and
Sr2+; (ii) binding a spectrum of signaling molecules such
as IP4 and (iii) binding to lipids such as phosphatidyli-
nositol 4,5-bisphosphate (PIP2), a plasma membrane
lipid with an essential role in exocytosis and endocytosis.
(iv) post-translational modifications (v) interacting mode
with the membrane; (vi) sensitivity of the promoters to
stress and hyper excitation and more. For example, Syt 7
is ~400-fold more sensitive to Ca2+ than is Syt1. By
replacing Ca2+ by Sr2+ and Ba2+ an uncoupling of the
binding to lipid and to t- SNAREs is achieved. Only few of
the Syts exhibit such uncoupling [42]. The complexity of
mammalian CNS can explain some of this intricacy, with
several of the Syt proteins expressed in the same cells. Fur-
thermore, tight regulation of expression of only some
members of the Syt family appears to be associated with
pathological states.
Multi-sensor proteins for presynaptic site organization
The time-scale of Syt1 in the control of NT release ranges
from millisecond (exocytosis) to seconds (endocytosis).
Other presynaptic proteins such as synapsins (Syns) act in
a much longer time frame ranging from minutes (facilita-
tion) to days (plasticity). Syns are a set of proteins sharing
features characteristic to SYNCONs, serve as multi-sensor
devices that modulate the organization of SV and in gen-
eral the architecture of presynaptic site [43].
In mammals, there are 3 genes that account for multiple
alternatively spliced variants of syn that are expressed in
the CNS. Knockout mice for one or even two or the Syn
genes showed only mild effects on brain development.
The main function of Syns is to bridge SVs to the cytoskel-
eton mesh through an interaction of F-actin and the SV
membranes [44]. Consequently, Syns affect the gross
morphology of the presynaptic site and primarily the
accessibility of SVs to engage in productive cycles of exo-
endocytosis.
What are the knobs that allow the switch of Syn from one
biochemical state to the other? All 3 Syn genes bind ATP
with a high affinity in a shared central domain of the pro-
tein. But while Syn1 binds ATP only in the presence of
Ca2+, Syn2 binds ATP irrespective of Ca2+, and Syn3
binds ATP only in the absence of Ca2+ [45]. Furthermore,
each of the Syn variants acts as a substrate for a combina-
Schematic illustration of the Ca2+ occupancy states for Syt1. Figure 3
Schematic illustration of the Ca2+ occupancy states 
for Syt1. The maximal number of Ca2+ ions (symbolized as 
red ovals) that can bind C2A is 3 (marked as 1,2,3) and 2 
(marked as 4, 5) for the C2B. The blue and purple lines rep-
resent all potential states ranging from no binding to maximal 
occupancy by 5 ions. Total of 12 edges representing Syt1 
states assuming the actual position of the ions within C2A or 
C2B is not important. Addition of the positional information 
increases the number of Ca2+ occupancy states as illustrated 
by the purple edges. The number of individual states associ-
ated with the purple edges summarizes to ten combinations 
of occupancy of 3 Ca2+ ions. With positional information for 
Ca2+ ions occupancy the number of individual states reaches 
32 (1 state for no occupancy, 5 states for one ion, 10 states 
for 2 ions, 10 states for 3 ions, 5 states for 4 ions and 
another state for occupancy of 5 ions).BMC Neuroscience 2006, 7(Suppl 1):S4
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tion of kinases and phosphatases [46,47]. Repression and
activation of these kinases and phosphatases are a direct
consequence of the amounts of signaling molecules such
as calmodulin, Ca2+ and cAMP. The outcome is a phos-
phorylation-dependent alteration in the capacity of Syns
to crosslink the SV with the actin mesh [48]. All Syn vari-
ants have a phosphorylation site for PKA and for CaMK I/
IV that is conserved across vertebrate and invertebrates
[49].  Syns can also be phosphorylated by CaMK II [50],
mitogen-activated protein kinase Erk, and cyclin depend-
ent kinase [51]. Thus, the actual level of phosphorylation
and their exact position on the protein produce a range of
biochemical entities that together determine the potential
of the synapse to efficiently respond to stimulation. As for
the other SYNCONs, Syns are engaged in multiple tran-
sient protein-protein interactions (Table 2). Syn was pro-
posed as an effector of Rab3, namely, its binding is fully
dependent on Rab3 GTP/GDP state [52]. Rab3 is a small
G-protein binding protein that is as a master switch that
determines the compatibility of SV for release [53]. The
binding of Syt for some partners is not only Ca2+ phos-
phorylation dependent but directly Ca2+ dependent (i.e.,
S100A) [54]. In addition to the molecular and cellular
level, mutations or polymorphic sites of these genes asso-
ciated with neurological impairments [55,56]. Human
genetic data ties specific polymorphic sites in Syn1 gene
with the ethiology and pathology of psychiatric disorders.
In a family with members affected by epilepsy, learning
disabilities and behavior disorders a mis-sense mutation
in Syn1 was detected. Similarly, a mutation in Syn3
resulted in learning impairments. The involvement of dif-
ferent Syn variants in protein interactions and in patho-
logical conditions is summarized in Table 2.
Synaptic proteins as information integrators
To fully appreciate the potential of molecules such as Syt1
and Syns as 'coincidence detector devices', quantitative
parameters on binding properties, on competition and
affinities and on modification of the molecules under
physiological setting are essential. Although our discus-
sion is limited to only two examples of SYNCONs, addi-
tional molecules in the synapse show similar molecular
coupling. A common observation for the 'multi-sensor
devices' which function in controlling NT transmission is
that mutations or even a subtle alteration in expression
level cause impairment in learning and behaviour. An
example is the NMDA glutamate receptor of the postsyn-
aptic membrane. NMDA controls aspects of plasticity,
neurotoxicity, learning and memory and is involved in the
symptoms of schizophrenia and other conditions [57].
Like Syt1 and Syns NMDA participates in a dynamic pro-
tein-protein interaction network.  The activity of NMDA
depends on post-translation modification scheme, on var-
iation in subunit assembly, alternative spliced variants,
trafficking, localization, internalization properties and the
binding of multiple ligands and ions. Integration of all
those variables specifies a large repertoire of NMDA vari-
ants that are identified by their biophysical and biochem-
ical properties. While NT release and postsynaptic
response are controlled by SYNCONs and NMDA, respec-
tively, additional multi-sensor proteins function in the
synapse. It was proposed that domains in a set of endocy-
totic proteins (i.e., Ampiphysin, Table 1) act as multi-sen-
sor by binding to different microenvironment of lipids. As
a result a membrane curvature is induced. Of course, the
efficiency of vesicle fusion, fission and cell division is
strongly dependent on the appropriate membrane curva-
ture [58].
Conclusion
The detailed analysis of Syts and Syns is used to illustrate
a common theme unifying all SYNCONs. Integration of
comparative genomic view, expression profile, biochemi-
cal data, subcellular localization and protein-protein
interactions is needed to describe the function of SYN-
CONs as proteins that adopt many discrete states and thus
play a fundamental role as multi-detector devices of the
synapse. Additional presynaptic proteins like Munc13,
Munc18, RIM and Rab3 (Table 1) share many of the fea-
tures of SYNCONs, though they function in a time scale
suitable for SVs maintenance and recovery [59]. A
dynamic model of functional synapse will include in-vivo
measurements from various SYNCONs. Such a model will
be the basis for constructing accurate simulation of a
behaving synapse and eventually, of a functional circuit in
the brain.
Table 2: Human synapsin (Syn) gene family.
Protein Length (aa)a Possible Exons Human-chromosome Disease Interactions
Synapsin 1 (Syn1) 705/669/261 16 Xp11.23 ALZ, epilepsy Rab3, S100A1, Actin, tubulin, 
CAPON, Syn1, Syn2, Syn3
Synapsin 2 (Syn2) 505/401/301/285 21 3p25.2 schizophrenia Actin, CAPON, PLCγ1, Syn1, 
Syn2, Syn3
Synapsin 3 (Syn3) 580/579/456/451/
236/192/(+ 4)
31 22q12.3 Schizophrenia Bipolar 
disorder Multiple sclerosis
Actin, CAPON, Syn1, Syn2, Syn3
aVariants listed are alternatively spliced forms. The expression of some of these variants is detected only under extreme stimulation conditions. The 
expression of some of these variants was not confirmed experimentally. Syns can form homo- and heterocomplexes among their family members.BMC Neuroscience 2006, 7(Suppl 1):S4
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